CN102697664A - Tanshinone lipidosome and preparation method thereof - Google Patents
Tanshinone lipidosome and preparation method thereof Download PDFInfo
- Publication number
- CN102697664A CN102697664A CN2012101822409A CN201210182240A CN102697664A CN 102697664 A CN102697664 A CN 102697664A CN 2012101822409 A CN2012101822409 A CN 2012101822409A CN 201210182240 A CN201210182240 A CN 201210182240A CN 102697664 A CN102697664 A CN 102697664A
- Authority
- CN
- China
- Prior art keywords
- liposome
- tanshinone
- emulsifying agent
- lecithin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses tanshinone lipidosome which takes tanshinone as the carrier and has the effects of resisting bacteria, resisting resistance, removing acne and eliminating acne marks. The tanshinone lipidosome is characterized in that the preparation method of the lipidosome is a propylene glycol injection method and the carrier comprises the following components according to weight percent: 0.01 to 5% of tanshinone, 8 to 25% of emulsifier, 2 to 18% of lecithin, and 0.1 to 1% of antioxidant, and the rest is deionized water, wherein the material of emulsifier is a compound taken from at least two of the following materials: Tween 20, Tween 60, Tween 80, PEG-200, alcohol, propylene glycol and 1,3-butanediol; the material of lecithin is taken from the following compounds: egg yolk lecithin and soya lecithin; and the antioxidant is vitamin E acetate. The lipidosome preparation agent has good stability and can carry high-content tanshinone; and the preparation method is simple and controllable, has good repeatability and can be applied to cosmetic for removing acne and eliminating acne marks.
Description
Technical field
The invention belongs to the carrier system technical field in the cosmetics technology of preparing, relate to a kind of nano carrier and preparation method thereof, particularly a kind of is the method for preparing of the liposome of active component with the TANSHINONES.
Background technology
Radix Salviae Miltiorrhizae cold nature bitter in the mouth has the effect of blood circulation promoting and blood stasis dispelling, nourishing blood to tranquillize the mind, menstruction regulating and pain relieving, removing heat from blood eliminating carbuncle, is the blood-activating stasis-removing kind Chinese medicine of using always.The content of TANSHINONES (tanshinone) in salviamiltiorrhizabung (SalviamiltiorrhizaBge) is higher, and stronger physiologically active is arranged, and is one of main effective ingredient of Radix Salviae Miltiorrhizae.Research shows that tanshinone all contains o-quinone or para-quinoid structure, has natural anti-oxidation effect, cardiovascular pharmacological effect and antibacterial and anti-inflammation functions.
TANSHINONES is supercritical (carbon dioxide) extract or the extract of organic solvents such as ether, alcohol of salviamiltiorrhizabung root, wherein contains multiple composition, the general name TANSHINONES.The various preparations of tanshinone medicine have been widely used in diseases such as treatment cardiovascular and cerebrovascular vessel, hepatitis, dermatosis and ulcer.TANSHINONES also has the effect of eliminating cutaneous pigmentation, speckle and treatment acne, has been applied in some functional cosmetics, but because of its poorly water-soluble, half-life weak point, has limited the application on market.
Liposome (liposome) is that Britain scholar Bangham and Standish found in nineteen sixty-five; 1971, people such as Lai Men began liposome is used for pharmaceutical carrier.Liposome is made up of phospholipid and additives, and phospholipid is amphiprotic substance, has hydrophilic and lipophilic group on its structure, and commonly used have lecithin, a fabaceous lecithin etc.Constitute the film forming surfaces externally and internally of hydrophilic stem shape of the lipoid of bilayer, and lipophilic end section is in the centre of film, wall thickness is about 5～7nm, and the diameter of capsule is generally between 25～50nm.This structure of liposome makes it can carry various hydrophilic or lyophobic dusts.Can be divided into according to structure and particle diameter: unilamelar liposome, multilamelar liposome, contain surface-active liposome etc.
Liposome is similar with biofilm structure, can stronger affinity be arranged with cell membrane, and penetrating ability that can the enhanced activity thing improves curative effect; Drug encapsulation becomes liposome, can prolong action time, reduces elimination factor; The release of active matter can be controlled after active matter is wrapped, it can be controlled in in-house distribution through the size that changes liposome.
Summary of the invention
The object of the invention is to provide the character that a kind of stability is high, TANSHINONES load content is high gentle cosmetics-stage Liposomal formulation, solved poorly water-soluble in the prior art, TANSHINONES content low, can not directly apply to problem such as cosmetics.
In order to solve these problems of the prior art, technical scheme provided by the invention is:
A kind of tanshinone liposome, said carrier loaded active ingredient is a TANSHINONES, it is characterized in that composition is counted by its percentage by weight in the said liposome:
All the other are deionized water;
Wherein phospholipid is selected from a kind of of following chemical compound: Ovum Gallus domesticus Flavus lecithin, soybean lecithin; Antioxidant is a Vitamin E acetate.
Preferably, said first emulsifying agent is selected from following chemical compound: polysorbas20, polysorbate60, Tween 80; Second emulsifying agent is a propylene glycol.
Another object of the present invention is to provide a kind of method for preparing described tanshinone liposome, it is characterized in that said method comprising the steps of:
(1) presses formula proportion weighing emulsifying agent, lecithin, TANSHINONES and antioxidant, with the raw materials mix post-heating and stir the homogeneous system of the oil phase that obtains being in a liquid state;
(2) press formula proportion weighing deionized water, heating obtains water;
(3) in 30-60 ℃ homogeneous system, add 30-60 ℃ water, in stir speed (S.S.) is the constant speed stirrer of 200r/min ~ 800r/min, stir 3 ~ 30min and obtain the liposome liquation;
(4) liposome liquation cool to room temperature is promptly got said tanshinone liposome.
Preferably, the particle mean size of the liposome particles that obtains of said method is at 0.1 ~ 20um.
Preferably, the emulsifying agent of said method use is that first emulsifying agent and second emulsifying agent combine according to formula proportion.
Another purpose of the present invention is to provide the application of a kind of said tanshinone liposome aspect the preparation skin protection cosmetics.
Composition is counted by its percentage by weight in the preferred tanshinone liposome:
All the other are deionized water.
The application of the liposome that another purpose of the present invention is to provide a kind of load that TANSHINONES is arranged aspect the preparation skin protection cosmetics.
The present invention is applied to nanotechnology in the cosmetic field.Defective to traditional handicraft has been carried out good improvement.Liposome is that the bilayer that constitutes with lipoids (like lecithin, cholesterol) is that the film material comprises the microgranule that forms.Liposome is as pharmaceutical carrier; Because of its phospholipid is biodegradable, nontoxic, non-immunogenicity, biocompatibility is very good, and self-isolation on the structure; Have protection medicine biological activity, effective control drug release, thereby reach effects such as prolong half-life, raising curative effect; And liposome type of having cellularity, thereby improve the therapeutic index of medicine, the dosage of minimizing medicine and the toxicity of reduction medicine.Liposome has advantages such as bioavailability height, Thermodynamically stable, viscosity be low, thereby can adopt liposomal systems to improve the bioavailability of TANSHINONES.
Utilize liposome technology that TANSHINONES is wrapped up, increase its load content, and improving its water solublity, can effectively to solve TANSHINONES not high at cosmetics product formula content, the problem of poorly water-soluble.
With respect to scheme of the prior art, advantage of the present invention is:
A kind of tanshinone liposome of the present invention is controlled.Can prepare TANSHINONES content through conditions such as attemperation, mixing speeds is 0.01 ~ 5% liposome.
Liposome preparation among the present invention technology improves its activity substance content, helps giving full play to the effect of the flat trace of anti-pox of active substance.The liposome stability of the present invention preparation is better, has good water solublity, makes that the preparation of the cosmetics that contain tanshinone liposome is convenient, simple.
The raw material of the tanshinone liposome that the present invention prepares and skin have the good compatibility, are easy to give full play to the effect of TANSHINONES.
Method for preparing of the present invention is simple, good reproducibility.Can it be added in the cosmetic formulations, or directly use.
Description of drawings
Below in conjunction with accompanying drawing and embodiment the present invention is further described:
Fig. 1 is the method for preparing flow chart of the present composition.
The specific embodiment
Below in conjunction with specific embodiment such scheme is further specified.These embodiment are used to the present invention is described and are not limited to limit scope of the present invention.The implementation condition that adopts among the embodiment can be done further adjustment according to the condition of concrete producer, and not marked implementation condition is generally the condition in the normal experiment.
The preparation of embodiment 1 tanshinone liposome
Composite formula
As shown in Figure 1, the preparation process of this embodiment is following:
1. take by weighing 2.5 gram soybean lecithins, 0.4 gram polysorbate60,8.0 gram propylene glycol, 0.2 gram Vitamin E acetate, 0.1 gram TANSHINONES is put into beaker, carries out 50 ℃ heating in water bath.
2. take by weighing 88.8 gram deionized waters and put into beaker, carry out 50 ℃ heating in water bath.
3. water is joined in the above-mentioned system, stir;
4. the high temperature liposomal systems that stirs is placed cooling and promptly get liposome, it is 10.38um that this liposome records its particle diameter through photon correlation spectroscopy (PCS).
The preparation of embodiment 2 tanshinone liposomes
Composite formula
As shown in Figure 1, the preparation process of this embodiment is following:
1. take by weighing 5.0 gram egg yolk lecithin, 1.4 gram polysorbas20s, 2.8 gram propylene glycol, 0.6 gram Vitamin E acetate, 1.2 gram TANSHINONESs are put into beaker, carry out 50 ℃ heating in water bath.
2. take by weighing 89.0 gram deionized waters and put into beaker, carry out 50 ℃ heating in water bath.
3. water is joined in the above-mentioned system, stir;
4. the high temperature liposomal systems that stirs is placed cooling and promptly get liposome, it is 6.36um that this liposome records its particle diameter through photon correlation spectroscopy (PCS).
The preparation of embodiment 3 tanshinone liposomes
Composite formula
As shown in Figure 1, the preparation process of this embodiment is following:
1. take by weighing 10.0 gram egg yolk lecithin, 3.6 gram Tween 80s, 12.6 gram propylene glycol, 0.6 gram Vitamin E acetate, 0.8 gram TANSHINONES is put into beaker, carries out 50 ℃ heating in water bath.
2. take by weighing 72.4 gram deionized waters and put into beaker, carry out 50 ℃ heating in water bath.
3. water is joined in the above-mentioned system, stir;
4. the high temperature liposomal systems that stirs is placed cooling and promptly get liposome, it is 0.86um that this liposome records its particle diameter through photon correlation spectroscopy (PCS).
The preparation of embodiment 4 tanshinone liposomes
Composite formula
As shown in Figure 1, the preparation process of this embodiment is following:
1. take by weighing 16.0 gram soybean lecithins, 4.5 gram polysorbate60s, 15.0 gram propylene glycol, 0.8 gram Vitamin E acetate, 2.0 gram TANSHINONESs are put into beaker, carry out 50 ℃ heating in water bath.
2. take by weighing 61.7 gram deionized waters and put into beaker, carry out 50 ℃ heating in water bath.
3. water is joined in the above-mentioned system, stir;
4. the high temperature liposomal systems that stirs is placed cooling and promptly get liposome, it is 7.38um that this liposome records its particle diameter through photon correlation spectroscopy (PCS).
Above-mentioned instance only is explanation technical conceive of the present invention and characteristics, and its purpose is to let the people who is familiar with this technology can understand content of the present invention and enforcement according to this, can not limit protection scope of the present invention with this.All equivalent transformations that spirit is done according to the present invention or modification all should be encompassed within protection scope of the present invention.
Claims (6)
1. tanshinone liposome, said carrier loaded active ingredient is a TANSHINONES, it is characterized in that composition is counted by its percentage by weight in the said liposome:
All the other are deionized water;
Wherein phospholipid is selected from a kind of of following chemical compound: Ovum Gallus domesticus Flavus lecithin, soybean lecithin; Antioxidant is a Vitamin E acetate.
2. tanshinone liposome according to claim 1 is characterized in that said first emulsifying agent is selected from following chemical compound: polysorbas20, polysorbate60, Tween 80; Second emulsifying agent is a propylene glycol.
3. method for preparing the described tanshinone liposome of claim 1 is characterized in that said method comprising the steps of:
(1) presses formula proportion weighing emulsifying agent, lecithin, TANSHINONES and antioxidant, with the raw materials mix post-heating and stir the homogeneous system of the oil phase that obtains being in a liquid state;
(2) press formula proportion weighing deionized water, heating obtains water;
(3) in 30-60 ℃ homogeneous system, add 30-60 ℃ water, in stir speed (S.S.) is the constant speed stirrer of 200r/min ~ 800r/min, stir 3 ~ 30min and obtain the liposome liquation;
(4) liposome liquation cool to room temperature is promptly got said tanshinone liposome.
4. according to the method for claim 3, the particle mean size that it is characterized in that the liposome particles that said method obtains is at 0.1 ~ 20um.
5. according to the method for claim 3, it is characterized in that the emulsifying agent that said method is used is that first emulsifying agent and second emulsifying agent combine according to formula proportion.
6. the application of the said tanshinone liposome of claim 1 aspect the preparation skin protection cosmetics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210182240 CN102697664B (en) | 2012-06-05 | 2012-06-05 | Tanshinone lipidosome and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210182240 CN102697664B (en) | 2012-06-05 | 2012-06-05 | Tanshinone lipidosome and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102697664A true CN102697664A (en) | 2012-10-03 |
| CN102697664B CN102697664B (en) | 2013-09-04 |
Family
ID=46890919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210182240 Expired - Fee Related CN102697664B (en) | 2012-06-05 | 2012-06-05 | Tanshinone lipidosome and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102697664B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104352439A (en) * | 2014-10-20 | 2015-02-18 | 河南牧翔动物药业有限公司 | Tiamulin lipidosome, preparation method and application thereof |
| CN104434580A (en) * | 2014-12-12 | 2015-03-25 | 唯美度科技（北京）有限公司 | Micro-emulsion containing tanshinone and preparation method and application of micro-emulsion containing tanshinone |
| CN104606063A (en) * | 2015-03-04 | 2015-05-13 | 王海龙 | Cosmetic active ingredient-containing lipidosome as well as preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100371028B1 (en) * | 2000-10-06 | 2003-02-06 | 주식회사 엘지생활건강 | Cosmetic composition containing Salvia militiorrhira Bge. extracts and polyethoxylated retinamide |
| CN101273971A (en) * | 2008-05-09 | 2008-10-01 | 绍兴文理学院 | Ethosomes preparation of antimycotics pharmaceutical and method for preparing the same |
| CN102397255A (en) * | 2011-11-24 | 2012-04-04 | 广东药学院 | Progesterone ethosome, and preparation method and application thereof |
-
2012
- 2012-06-05 CN CN 201210182240 patent/CN102697664B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100371028B1 (en) * | 2000-10-06 | 2003-02-06 | 주식회사 엘지생활건강 | Cosmetic composition containing Salvia militiorrhira Bge. extracts and polyethoxylated retinamide |
| CN101273971A (en) * | 2008-05-09 | 2008-10-01 | 绍兴文理学院 | Ethosomes preparation of antimycotics pharmaceutical and method for preparing the same |
| CN102397255A (en) * | 2011-11-24 | 2012-04-04 | 广东药学院 | Progesterone ethosome, and preparation method and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| 《中成药》 20051231 陆晓红 丹参酮脂质传递体的制备及体外经皮渗透研究 1001-1003 1-6 第27卷, 第9期 * |
| 张明等人: "应用不同类型脂质体作为姜黄素经皮给药载体的实验研究", 《温州医学院学报》, vol. 41, no. 4, 31 July 2011 (2011-07-31), pages 324 - 328 * |
| 陆晓红: "丹参酮脂质传递体的制备及体外经皮渗透研究", 《中成药》, vol. 27, no. 9, 31 December 2005 (2005-12-31), pages 1001 - 1003 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104352439A (en) * | 2014-10-20 | 2015-02-18 | 河南牧翔动物药业有限公司 | Tiamulin lipidosome, preparation method and application thereof |
| CN104434580A (en) * | 2014-12-12 | 2015-03-25 | 唯美度科技（北京）有限公司 | Micro-emulsion containing tanshinone and preparation method and application of micro-emulsion containing tanshinone |
| CN104606063A (en) * | 2015-03-04 | 2015-05-13 | 王海龙 | Cosmetic active ingredient-containing lipidosome as well as preparation method and application thereof |
| CN104606063B (en) * | 2015-03-04 | 2021-07-16 | 王海龙 | Liposome containing cosmetic active ingredients and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102697664B (en) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102688151B (en) | Tanshinone microemulsion and preparation method thereof | |
| Yang et al. | Encapsulating plant ingredients for dermocosmetic application: An updated review of delivery systems and characterization techniques | |
| CN103565743B (en) | Tranexamic acid external preparation for skin nanometer formulation and its production and use | |
| CN106691888B (en) | Glabridin nano composition with high skin retention and preparation method and application thereof | |
| Sarangi et al. | Novel herbal drug delivery system: An overview | |
| CN103571657A (en) | Natural soap for removing poxes as well as preparation method thereof | |
| CN104146957A (en) | Submicroemulsion antifungal drug spray preparation | |
| CN101396344A (en) | Paeonol microemulsion preparation and preparation method thereof | |
| CN101919805B (en) | Freeze-dried molded products containing magnesium ascorbyl phosphate | |
| CN109498478A (en) | A kind of fullerene topical composition | |
| CN102697664B (en) | Tanshinone lipidosome and preparation method thereof | |
| US20220054427A1 (en) | Transdermal composition | |
| CN102552565A (en) | Oil-in-water compound grape seed oil nanoemulsion breast enlargement preparation and preparation method thereof | |
| CN106833974A (en) | A kind of bamboo charcoal handmade soap of oil control and acne removal and preparation method thereof | |
| CN108670945A (en) | A kind of nanogel preparation and preparation method thereof with double slow releasing functions | |
| KR102061613B1 (en) | Manufacturing method of cosmetic composition having deodorization and antimicrobial effect using microcapsule adsorbed with asarum oil and cosmetic composition including the same | |
| CN104383551A (en) | Traditional Chinese medicine soft capsule auxiliary material with universality and method for preparing traditional Chinese medicine soft capsules | |
| CN201658672U (en) | Improved dogskin plaster | |
| Kaur et al. | Formulation strategies and therapeutic applications of shikonin and related derivatives | |
| CN104337711A (en) | A breast enlargement care product containing southern magnolia seed oil | |
| CN102166236B (en) | Oil-in-water type notopterygium oil nano emulsion oral liquid and preparation method thereof | |
| Saxena et al. | Design and characterization of dual‐pronged liposome‐embedded gel for enhanced dermal delivery | |
| KR20130109282A (en) | Water soluble caffeine and preparing method thereof | |
| CN106860188A (en) | Beauty moisturizing nanometer creams | |
| CN102688153A (en) | Blank liposome prepared by compounding phospholipid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130904 Termination date: 20190605 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |